File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.yhbeh.2006.09.004
- Scopus: eid_2-s2.0-33751546194
- PMID: 17049519
- WOS: WOS:000243645100016
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effects of testosterone and corticosterone on immunocompetence in the zebra finch
Title | Effects of testosterone and corticosterone on immunocompetence in the zebra finch |
---|---|
Authors | |
Keywords | Immunocompetence handicap hypothesis PHA Stress Testosterone Zebra finch Corticosterone Diphtheria:tetanus Glucocorticoid Immunocompetence |
Issue Date | 2007 |
Citation | Hormones and Behavior, 2007, v. 51, n. 1, p. 126-134 How to Cite? |
Abstract | The original immunocompetence handicap hypothesis (ICHH) suggested that testosterone has a handicapping effect in males by both promoting the development of sexual signals and suppressing immune function. A modified version, the stress-linked ICHH, has recently proposed that testosterone is immunosuppressive indirectly by increasing production of corticosterone. To test both the original and stress-mediated versions of the ICHH, we implanted male zebra finches taken from lines selected for divergent maximum stress-induced levels of corticosterone (high, low and control) with either empty or testosterone-filled implants. Their humoral and cell-mediated immune responses were then assessed by challenge with diphtheria:tetanus vaccine and phytohemagglutinin respectively. We found no effect of the hormone manipulations on either PHA or tetanus antibody responses, but found a significant interaction between titers of both testosterone and corticosterone on diphtheria secondary antibody response; antibody response was greatest in individuals with high levels of both hormones. There was also a significant interactive effect between testosterone treatment group and corticosterone titer on body mass; the body mass of males in the elevated testosterone treatment group decreased with increasing corticosterone titer. These results suggest that, contrary to the assumption of the stress-mediated version of the ICHH, high plasma levels of corticosterone are not immunosuppressive, but are in fact immuno-enhancing in the presence of high levels of plasma testosterone. Equally, the central assumption of the ICHH that testosterone is obligately immunosuppressive is also not supported. The same individuals with the highest levels of both hormones and consequently the most robust antibody response also possessed the lowest body mass. © 2006 Elsevier Inc. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/230771 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 0.936 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Roberts, Mark L. | - |
dc.contributor.author | Buchanan, Katherine L. | - |
dc.contributor.author | Hasselquist, Dennis | - |
dc.contributor.author | Evans, Matthew R. | - |
dc.date.accessioned | 2016-09-01T06:06:46Z | - |
dc.date.available | 2016-09-01T06:06:46Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Hormones and Behavior, 2007, v. 51, n. 1, p. 126-134 | - |
dc.identifier.issn | 0018-506X | - |
dc.identifier.uri | http://hdl.handle.net/10722/230771 | - |
dc.description.abstract | The original immunocompetence handicap hypothesis (ICHH) suggested that testosterone has a handicapping effect in males by both promoting the development of sexual signals and suppressing immune function. A modified version, the stress-linked ICHH, has recently proposed that testosterone is immunosuppressive indirectly by increasing production of corticosterone. To test both the original and stress-mediated versions of the ICHH, we implanted male zebra finches taken from lines selected for divergent maximum stress-induced levels of corticosterone (high, low and control) with either empty or testosterone-filled implants. Their humoral and cell-mediated immune responses were then assessed by challenge with diphtheria:tetanus vaccine and phytohemagglutinin respectively. We found no effect of the hormone manipulations on either PHA or tetanus antibody responses, but found a significant interaction between titers of both testosterone and corticosterone on diphtheria secondary antibody response; antibody response was greatest in individuals with high levels of both hormones. There was also a significant interactive effect between testosterone treatment group and corticosterone titer on body mass; the body mass of males in the elevated testosterone treatment group decreased with increasing corticosterone titer. These results suggest that, contrary to the assumption of the stress-mediated version of the ICHH, high plasma levels of corticosterone are not immunosuppressive, but are in fact immuno-enhancing in the presence of high levels of plasma testosterone. Equally, the central assumption of the ICHH that testosterone is obligately immunosuppressive is also not supported. The same individuals with the highest levels of both hormones and consequently the most robust antibody response also possessed the lowest body mass. © 2006 Elsevier Inc. All rights reserved. | - |
dc.language | eng | - |
dc.relation.ispartof | Hormones and Behavior | - |
dc.subject | Immunocompetence handicap hypothesis | - |
dc.subject | PHA | - |
dc.subject | Stress | - |
dc.subject | Testosterone | - |
dc.subject | Zebra finch | - |
dc.subject | Corticosterone | - |
dc.subject | Diphtheria:tetanus | - |
dc.subject | Glucocorticoid | - |
dc.subject | Immunocompetence | - |
dc.title | Effects of testosterone and corticosterone on immunocompetence in the zebra finch | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.yhbeh.2006.09.004 | - |
dc.identifier.pmid | 17049519 | - |
dc.identifier.scopus | eid_2-s2.0-33751546194 | - |
dc.identifier.volume | 51 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 126 | - |
dc.identifier.epage | 134 | - |
dc.identifier.eissn | 1095-6867 | - |
dc.identifier.isi | WOS:000243645100016 | - |
dc.identifier.f1000 | 1058002 | - |
dc.identifier.issnl | 0018-506X | - |